Form 4: Accelerate Diagnostics Executive Larry Mertz Reports Stock Transactions
SEC Form 4 Filing
Larry Mertz, Chief Technology Officer of Accelerate Diagnostics, reports the vesting and sale of restricted stock units to cover tax obligations.
Summary
- On May 20, 2024, Larry Mertz, the Chief Technology Officer of Accelerate Diagnostics, Inc., reported transactions involving common stock.
- Mertz acquired 1,000 shares and 283 shares of common stock through the vesting of restricted stock units (RSUs).
- Simultaneously, Mertz sold 275 shares and 86 shares at $0.88 per share to cover tax withholding obligations related to the RSU vesting.
- Following these transactions, Mertz beneficially owns 82,028 shares of Accelerate Diagnostics, Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports routine stock transactions related to RSU vesting and tax obligations.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment or misalignment of interests between management and shareholders.
Stakeholder Impact
- The transactions have a minimal impact on stakeholders as they are related to routine executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/20/2021 | Reporting person was granted a total of 3,000 RSUs, which vest in equal amounts every year over three years, which started vesting on May 20, 2022. |
| 05/20/2021 | Reporting person was granted a total of 850 RSUs, which vest in equal amounts every year over three years, which started vesting on May 20, 2022. |
| 05/20/2024 | Date of stock transactions: vesting of RSUs and sale of shares to cover taxes. |
| 05/21/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.